Neural Stem Cell Transplantation Offers Hope to Children with Rare but Incurable and Fatal Batten Disease
Researchers investigated the transplantation of neural stem cells in patients with advanced stage infantile and late-infantile Neuronal Ceroid Liposfuscinosis. [Press release from Oregon Health & Science University discussing research presented at the 78th Annual Meeting of the American Association of Neurological Surgeons]
New Method Reveals How Individual Nerve Cells Process Visual Input
Pioneering a novel microscopy method, neuroscientists have shown that individual neurons carry out significant aspects of sensory processing: specifically, in this case, determining which direction an object in the field of view is moving. [Press release from Technische Universität München discussing online prepublication in Nature]
Treating Battlefield Injuries with Light-Activated Technology
This new treatment for war injuries includes using a process or technology called Photochemical Tissue Bonding, which can replace conventional sutures, staples and glues in repairing skin wounds, reconnecting severed peripheral nerves, blood vessels, tendons and incisions in the cornea. [Air Force Office of Scientific Research Press Release]
Human Embryonic Stem Cell-Derived Neurons as a Tool for Studying Neuroprotection and Neurodegeneration
Far from replacing rodent in vivo and primary culture systems, human embryonic stem and induced disease-specific pluripotent stem cell-derived neurons offer a complementary resource to overcome issues of interspecies differences, accelerate drug discovery, study of disease mechanism and provide basic insight into human neuronal physiology. [Mol Neurobiol]
The Signals of FGFs on the Neurogenesis of Embryonic Stem Cells
By using a serum-free neural induction method, researchers showed that FGF1 dose-dependently promoted the induction of Sox1/N-cadherin/nestin triple positive cells, which represent primitive neuroblasts, from mouse embryonic stem cells. [J Biomed Sci]
New Positive Data Regarding ReNeuron's Stem Cell Line for Stroke to be Presented at U.S. Conference
ReNeuron Group plc announces that positive data from a number of new pre-clinical studies using its CTX stem cell line for stroke will be presented in an oral presentation and posters at the 17th Annual Conference of the American Society for Neural Therapy and Repair. [ReNeuron Group plc Press Release]
Mesoblast Completes Enrolment for First Spinal Fusion Trial
Mesoblast’s first trial evaluating its proprietary allogeneic, or "off-the-shelf", stem cells for posterolateral lumbar spinal fusion, at New York’s Hospital for Special Surgery, has now completed enrolment, and has been fully reviewed by the Data Safety and Monitoring Board. [Mesoblast Limited Press Release]
McKnight Brain Institute Researchers Receive $250,000 to Study Cell-Based Epilepsy Treatment
University of Florida researchers will receive $250,000 to study an inventive cell-transfer therapy to treat cortical dysplasia, a condition where the brain develops abnormally before birth, causing severe epilepsy in children and adults. [University of Florida Health Science Center Press Release]
In Montgomery County, Plans for Bioscience Development Nears Approval
Plans for a "science city" in Montgomery County are expected to win approval from the County Council, a move that officials hope will lead to the creation of a $10 billion, 17.5 million-square-foot center for research and development. [Washington Post]
Collins Tells Congress NIH Budget Will Pay Off
National Institutes of Health Director Francis Collins went to Capitol Hill to express his support for President Barack Obama's proposed 2011 budget for the institutes. [National Institutes of Health, United States]
Science Panel Cuts Authorization Levels for Three COMPETES Agencies
The House of Representatives Science and Technology Committee scaled back proposed funding levels for three key science agencies as part of its reauthorization of the America COMPETES Act. [The House of Representatives Science and Technology Committee, United States]
$11.5 Million for Stem Cell Therapy Research
Ontario's provincial government has announced $11.5 million in funding support for researchers at McMaster University, who are developing stem cell-based therapies. [Global Leadership Round in Genomics & Life Sciences, Canada]
CIRM Awards $28 Million to Answer Fundamental Questions in Stem Cell Biology
At a meeting at the City of Hope, the governing board of the California Institute for Regenerative Medicine (CIRM), the state stem cell agency created by Proposition 71, approved funding $28 million to support 16 Basic Biology II Awards that answer fundamental questions about stem cell biology and one Leadership Award. [California Institute for Regenerative Medicine, United States]
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Neural Cell News.
Visit here to post your career opportunities.
